Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Delta Lloyd was a prominent Dutch financial services provider that operated extensively in the insurance and pension sectors. Within the healthcare industry, the company was a major health insurer in the Netherlands, offering a variety of health insurance products and services through its subsidiary, Delta Lloyd Zorgverzekering. Additionally, the group managed specialized investment funds, such as the Delta Lloyd L Health Care Fund, which focused on global pharmaceutical and biotechnology equities. In 2017, Delta Lloyd was acquired by NN Group (Nationale-Nederlanden) for approximately €2.3 billion, leading to the integration of its healthcare portfolio into NN's operations. The brand has since been retired as part of the consolidation within the Dutch insurance market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Delta Lloyd.